Company: MBIO
Filing Date: 2025-02-07
Form Type: 424B4
Source: 0001410578-25-000085
Chunk: 88

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-07
Form: 424B4
Chunk 88
---
M”) program; and |

| ● | on a pro forma as adjusted basis to give effect to (i) the pro forma adjustments described above and (ii) the issuance and sale by us of  495,000 shares of common stock, pre-funded warrants to purchase up to  2,162,807 shares of common stock, and accompanying Series C-1 Warrants to purchase up to 2,657,807 shares of common stock and Series C-2 Warrants to purchase up to 2,657,807 shares of common stock at a public offering price of $3.01 per share, and after deducting Placement Agent fees and estimated offering expenses payable by us, and assuming exercise in full of any pre-funded warrants offered in this offering, no exercise of the Warrants being offered in this offering, that no value is attributed to such Warrants and that such Warrants are classified as and accounted for as equity. |

You should read this table together with “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as our financial statements and related notes and the other financial information appearing elsewhere in this prospectus. The information presented in the capitalization table has been adjusted to reflect the effect of this current offering.

| ​                                                                                                                                                          
 ​                                                                                                                                                          | ​ 
 ​ | ​                  
 September 30, 2024 |          | ​ | ​         |        ​ | ​ | ​            |        ​ | ​ 
 ​ |
|:-----------------------------------------------------------------------------------------------------------------------------------------------------------|:--|:-------------------|---------:|:--|:----------|---------:|:--|:-------------|---------:|:--|
| ​                                                                                                                                                          | ​ | -unaudited         |          |   |           |          |   |              |          | ​ |
| ​                                                                                                                                                          | ​ | ​                  |          | ​ | ​         |        ​ | ​ | Pro Forma As |          | ​ |
| ($ in thousands, except share and per share amounts)                                                                                                       | ​ | Actual             |          | ​ | Pro Forma |          | ​ | Adjusted     |          | ​ |
| Cash and cash equivalents                                                                                                                                  |   | $                  |    3,525 |   | $         |    9,132 |   | $            |   16,048 | ​ |
| Stockholders’ Equity (Deficit)                                                                                                                             | ​ | ​                  |        ​ | ​ | ​         |        ​ | ​ | ​            |